RxDoctor Payments Data

Christy Hearne, NP

Adult Health · Asheboro, NCNPI 1760885271

Payments from drug & device makers

$964in general payments, 2019–2025

Across 55 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$138
  • Novo Nordisk$109
  • Bayer$95
  • Lilly USA, LLC$88
  • Neurocrine Biosciences, Inc.$76
  • Eisai Inc.$55
  • plus $402 from 21 others

What the payments were for

  • Food & beverage$964100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$964 in reported general payments places this provider in the 60th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Medicare billing

Part B allowed, 2024
$200,179
Medicare patients
135
Services billed
1,831

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban178$108,675
MyrbetriqMirabegron84$41,209
TrulicityDulaglutide17$17,567
FarxigaDapagliflozin Propanediol24$14,584
XareltoRivaroxaban20$11,775
JanuviaSitagliptin Phosphate18$10,649
Memantine Hcl233$10,339
NamzaricMemantine Hcl/Donepezil Hcl16$9,420
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$9,075
Memantine Hcl ErMemantine Hcl44$6,317
EntrestoSacubitril/Valsartan14$5,863
Donepezil Hcl336$5,320
Breo ElliptaFluticasone/Vilanterol12$5,188
Divalproex Sodium83$5,158
Potassium Chloride260$4,554

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$88$17,56717 claims
AstraZenecaFarxiga$34$14,58424 claims
GSKTrelegy Ellipta, Breo Ellipta$16$14,26225 claims
Johnson & JohnsonXarelto$13$11,77520 claims
AbbVieNamzaric$138$9,42016 claims
NovartisEntresto$23$5,86314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 614 adult health providers in North Carolina.

Other adult health in Asheboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →